|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Association of anemia and physical disability among patients with rheumatoid arthritis显示文摘 | Han C Rahman MU Doyle MK | | 0，，11： | 1 |
| 2 | Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFrER study) : a mul- ticentre, randomised, double-blind, placebo-controlled, phase Ⅲ trial显示文摘 | Smolen JS Kay J Doyle MK | 2009 | Lancet2009，374，9685： | 1 |
| 3 | Health-related qualityof life in patients with pulmonary arteri hypertension显示文摘 | Shafazand S Goldstein MK Doyle RL | 2004 | Chest2004，126，5： | 1 |
| 4 | Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis:A meta-analysis of randomized,controlled trials显示文摘 | Gould MK Dembitzer AD Doyle RL | | 0，，10： | 1 |
| 5 | Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis:results of an analysis of the literature over the past 16 years显示文摘 | Rahman MU Buchanan J Doyle MK | | 0，，09： | 1 |
| 6 | Association of anemia and physical disability among patients with rheumatoid arthritis显示文摘 | Han C Rahman MU Doyle MK | 2007 | J Rheumatol2007，34，： | 1 |
| 7 | Effects of subcutaneous and intravenous golimumab on inflammatory biomarkers in patients with rheumatoid arthritis:results of a phase 1,randomized,open-label trial显示文摘 | Doyle MK Rahman MU Frederick B | 2013 | Rheumatology(Oxford)2013，52，7： | 1 |
| 8 | Changes in pa- tient characteristics in anti - tumour necrosis factor clinical trails for rheumatoid arthritis ; results of an analysis of the literature o- ver the past 16 years 显示文摘 | Rahman MU Buchanan J Doyle MK | 2011 | ANN Rheum Dis2011，70，9： | 1 |
| 9 | Association of anemia and physical dis- ability among patients with rheumatoid ar- thritis 显示文摘 | Han C gahman MU Doyle MK | 2007 | J Rheumatol2007，34，11： | 1 |
| 10 | Low-molec- ular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis: a meta-analysis ofrandomized, controlled trials 显示文摘 | GOULD MK DEMBITZER AD DOYLE RL | 1999 | Ann Intern Med1999，130，10： | 1 |
| 11 | Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AF-TER study):a multicentre,randomized,double-blind,placebo-controlled,phase Ⅲ trial显示文摘 | Smolen JS Kay J Doyle MK | | 0，，9685： | 1 |
| 12 | Changes in patientcharacteristics in anti-tumour necrosis factor clinical trials forrheumatoid arthritis:results of an analysis of the literatureover the past 16years显示文摘 | Rahman MU Buchanan J Doyle MK | 2011 | Ann Rheum Dis2011，70，9： | 1 |
| 13 | Completeness of notiflable infectious disease reporting in the United States: an analytical lit- erature review 显示文摘 | Doyle TJ Glynn MK Groseclose SL | 2002 | Am J Epidemiol2002，155，9： | 1 |
| 14 | Effects of subcutaneous and intravenous golimumab on inflammatory hiomarkers in patients with rheumatoid arthritis : results of a phase 1, randomized, open - label trial显示文摘 | Doyle MK Rahman MU Frederick B | 2013 | Rheumatology2013，52，7： | 1 |
| 15 | Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhihitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial 显示文摘 | SMOLEN JS KAY J DOYLE MK | 2009 | Lancet2009，374，9685： | 1 |
| 16 | Low molecular weight hepza'ins compared with unfractionated heparin for treatment ofacute deep venous thrombosis显示文摘 | Gould MK Dembitzer AD Doyle RL | 1999 | Ann Intern Med1999，130，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员